Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, calcitonin, and furosemide administration for hypercalcemia of malignancy

Journal of the American Animal Hospital Association

Volumn 40, Issue 1, 2004, Pages 75-81

  Kadar, Elissa ^a   Rush, John E ^a   Westmore, Lois ^a   Chan, Daniel L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CIMETIDINE; DIAZEPAM; DOPAMINE; FUROSEMIDE; GLYCOPYRRONIUM BROMIDE; HYDROMORPHONE; ISOFLURANE; MAGNESIUM SULFATE; OXYGEN; OXYMORPHONE; PAMIDRONIC ACID; POTASSIUM CHLORIDE; PROPOFOL; RINGER LACTATE SOLUTION; SELEGILENE; SODIUM CHLORIDE;

ADENOCARCINOMA; ANESTHESIA INDUCTION; ANUS CARCINOMA; ANUS SURGERY; ARTICLE; DISEASE ASSOCIATION; DOG; ELECTROLYTE DISTURBANCE; HEART ARRHYTHMIA; HYPERCALCEMIA; HYPOMAGNESEMIA; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DOCUMENTATION; NONHUMAN;

CANIS FAMILIARIS;

EID: 13544260612     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0400075     Document Type: Article

References (26)

1. DeNovo RC Jr, Bright RM. Recto-anal disease. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 5th ed. Philadelphia: WB Saunders, 2000:1257-1270.
2. Ross JT, Scavelli TD, Mathiesen DT, Patnaik AK. Adenocarcinoma of the apocrine glands of the anal sac in dogs: a review of 32 cases. J Am Anim Hosp Assoc 1991;27:349-355.
3. Rosol TJ, Capen CC, Danks JA, et al. Identification of parathyroid hormone-felated protein in canine apocrine adenocarcinoma of the anal sac. Vet Pathol 1990;27:89-95.
4. Martin L. Hypercalcemia and hypermagnesemia. Vet Clin North Am Sm Anim Pract 1998;28:587-608.
5. Nussbaum SR, Younger J, Vandepol CJ, et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia: comparison of 30-,60-,90-mg doses. Am J Med 1993;95:297-304.
6. Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet 1985;2(8461):907-910.
7. Plumb DC. Veterinary drug handbook. 3rd ed. Ames: Iowa State Univ Press, 1999:297-299.
8. Young G, Shende A. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr Onc 1998;30:117-121.
9. Body JJ, Bartl R, Burckhardt P, et al. Current use of bisphosphonates in oncology. J Clin Oncol 1998;16:3890-3899.
10. Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000;27:322-334.
11. Nussbaum SR. Pathophysiology and management of severe hypercalcemia (review). Endocrinol Metab Clin North Am 1993;22:343-362.
12. Rhumbeiha WK, Fitzgerald SF, Kruger JM, et al. Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs. Am J Vet Res 2000;61:9-13.
13. 3-induced toxicosis in dogs. Am J Vet Res 1999;60:1092-1097.
14. Elisaf M, Kalaitzidis R, Siamopoulos KC. Multiple electrolyte abnormalities after pamidronate administration. Nephron 1998;79:337-339.
15. Package insert for aredia, pamidronate disodium. Novartis pharmaceutical corporation, East Hanover, NJ 2001.
16. Machado CE, Flombaum CD. Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Neph 1996;45:175-179.
17. Dhupa N, Proulx J. Hypocalcemia and hypomagnesemia (review). Vet Clin North Am Sm Anim Pract 1998;28:565-585.
18. Bean BL, Varghese PJ. Role of dietary magnesium deficiency in the pressor and arrhythmogenic response to epinephrine in the intact dog. Am Heart J 1994; 127:96-102.
19. Martin LG, Matteson VL, Wingfield WE, Van Pelt DR, Hackett TB. Abnormalities in serum magnesium in critically ill dogs: incidence and implications. J Vet Emerg Crit Care 1994;4:15-20.
20. Schaer M. Disorders of serum potassium, sodium, magnesium and chloride. J Vet Emerg Crit Care 1999;9:209-217.
21. Martin HE. Clinical magnesium deficiency. Ann NY Acad Sci 1969;162:891-900.
22. Khanna C, Lund EM, Raffe M, Armstrong PJ. Hypomagnesemia in 188 dogs: a hospital population-based prevalence study. J Vet Int Med 1998;12:304-309.
23. Roden DM, Iansmith DH. Effects of low potassium or magnesium concentrations on isolated cardiac tissue. Am J Med 1987;82:18-23.
24. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. J Am Med Assoc 1992;268:2395-2402.
25. Varma N, Kerrigan GNW. Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate. Postgrad Med J 1993;69:497-500.
26. Oguchi Y, Hamlin RL. Duration of QT interval in clinically normal dogs. Am J Vet Res 1993;54:2145-2149.